21-46297594-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001314025.2(YBEY):c.464G>A(p.Arg155Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000188 in 1,380,660 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001314025.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
YBEY | NM_001314025.2 | c.464G>A | p.Arg155Gln | missense_variant | 5/5 | ENST00000397701.9 | NP_001300954.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
YBEY | ENST00000397701.9 | c.464G>A | p.Arg155Gln | missense_variant | 5/5 | 2 | NM_001314025.2 | ENSP00000380813.4 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152226Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000167 AC: 11AN: 65706Hom.: 1 AF XY: 0.000304 AC XY: 11AN XY: 36146
GnomAD4 exome AF: 0.000190 AC: 233AN: 1228316Hom.: 4 Cov.: 30 AF XY: 0.000217 AC XY: 130AN XY: 598700
GnomAD4 genome AF: 0.000177 AC: 27AN: 152344Hom.: 0 Cov.: 34 AF XY: 0.000188 AC XY: 14AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2024 | The c.464G>A (p.R155Q) alteration is located in exon 5 (coding exon 4) of the YBEY gene. This alteration results from a G to A substitution at nucleotide position 464, causing the arginine (R) at amino acid position 155 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at